Online Program

Population Health in Health Care Systems: The Role of Preventive Medicine in Health Systems Transformation

Monday, November 2, 2015 : 1:00 p.m. - 1:15 p.m.

Michael Barry, CAE, American College of Preventive Medicine, Washington, DC

This presentation will introduce the medical specialty of Preventive Medicine (PM) and how physicians who specialize in PM serve as boundary spanners in communities and health care institutions to bridge the divide between clinical care and population health.  It will describe why this integration is so important to health systems transformation (HST) and provide information about the American College of Preventive Medicine’s strategic initiatives focused on HST and how to infuse population health in health care systems.  Lastly, it will highlight the unique training of PM residents, describe how such training positions these physicians as leaders in integration efforts, and encourage communities to seek out PM physicians to further any integration work that may be underway or being considered.

Learning Areas:

Public health or related education

Learning Objectives:
Identify Preventive Medicine physicians in health care institutions or communities and engage these physicians in health system transformation efforts that seek to bridge clinical care with population health improvement.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Executive Director of the American College of Preventive Medicine, the national professional society for physicians dedicated to prevention. Having been with ACPM for 16 years and executive director for 10 years, I have overseen numerous activities, including federally-funded projects, focused on improving population health and the uptake of both clinical and community preventive services and understand the unique training and expertise of Preventive Medicine physicians and how they contribute to community-clinical linkages.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.